news Novel target could improve the efficacy of treatments for renal cell carcinoma 21 January 2021 | By Hannah Balfour (Drug Target Review) A new study shows that upregulating the activity of the ACE2 signalling pathway in kidney cancer cells enhances the effects of clinically used treatments.
news Nanotherapy offers hope in treating drug-resistant renal cell carcinoma 24 September 2018 | By Drug Target Review A research team has developed a nano-platform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma...